ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,099,000 | -10.2% | 88,482 | -52.7% | 0.01% | 0.0% |
| Q1 2019 | $4,566,000 | +804.2% | 187,257 | +463.0% | 0.01% | +700.0% |
| Q3 2018 | $505,000 | -72.1% | 33,259 | -69.1% | 0.00% | -75.0% |
| Q2 2018 | $1,808,000 | +134.2% | 107,730 | +127.9% | 0.00% | +100.0% |
| Q1 2018 | $772,000 | -76.0% | 47,281 | -81.2% | 0.00% | -80.0% |
| Q4 2017 | $3,217,000 | +137.1% | 251,306 | +127.6% | 0.01% | +150.0% |
| Q3 2017 | $1,357,000 | +534.1% | 110,397 | +331.5% | 0.00% | +300.0% |
| Q2 2017 | $214,000 | +43.6% | 25,585 | +53.2% | 0.00% | 0.0% |
| Q1 2017 | $149,000 | -38.2% | 16,700 | -39.0% | 0.00% | 0.0% |
| Q4 2016 | $241,000 | -75.8% | 27,396 | -81.4% | 0.00% | -75.0% |
| Q3 2016 | $994,000 | +2912.1% | 147,153 | +1202.0% | 0.00% | – |
| Q1 2016 | $33,000 | -65.6% | 11,302 | -50.4% | 0.00% | – |
| Q4 2015 | $96,000 | -40.7% | 22,800 | -36.0% | 0.00% | -100.0% |
| Q3 2015 | $162,000 | +19.1% | 35,627 | -6.8% | 0.00% | 0.0% |
| Q3 2014 | $136,000 | -1.4% | 38,219 | +26.2% | 0.00% | -50.0% |
| Q2 2014 | $138,000 | – | 30,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |